Latest News in the pharma Industry

Top Stories

Bayer Anti-clotting Drug Wins FDA Approval

Bayer Anti-clotting Drug Wins FDA Approval

8 Nov 2011

Bayer Healthcare's anti-clotting drug Xarelto has won FDA approval to treat stroke in people with an abnormal heart rhythm.

Read more 
DKSH and Hanseo Chemical Ink Pact for GPC

DKSH and Hanseo Chemical Ink Pact for GPC

8 Nov 2011

DKSH has signed a global exclusive agreement to distribute Hanseo Chemical's glycerophosphatidylcholin.

Read more 
Horizon & Promega Ink Predictive Disease Model Pact

Horizon & Promega Ink Predictive Disease Model Pact

8 Nov 2011

The partnership aims to develop next-generation predictive human disease models as they occur in patient tumors.

Read more 
Alios BioPharma & Versitech Sign for Influenza Therapy

Alios BioPharma & Versitech Sign for Influenza Therapy

7 Nov 2011

The two companies have announced an exclusive worldwide licensing agreement to advance the research, development, manufacture and commercialization of novel medicines to treat influenza infection.

Read more 
35 New Drugs Approved by FDA over the Past 12 Months

35 New Drugs Approved by FDA over the Past 12 Months

7 Nov 2011

Over the past 12 months, the US FDA approved 35 new medicines and 24 of the approvals occurred in the US.

Read more 
India Plans to Boost Pharma Export to African Countries

India Plans to Boost Pharma Export to African Countries

7 Nov 2011

India's Ministry of Commerce and Industry has called for suggestions from all the Indian pharma companies to boost the African markets.

Read more 
BMS & ASLAN Team up for Investigational Therapy

BMS & ASLAN Team up for Investigational Therapy

4 Nov 2011

Under the terms of the agreement, ASLAN will run and fund development of BMS-777607 under a pre-agreed development program that will initially target gastric cancer and lung cancer.

Read more 
Teva and P&G Establish JV with Focus on OTC Medicines

Teva and P&G Establish JV with Focus on OTC Medicines

4 Nov 2011

PGT Healthcare, as the new JV will be called, is expected to realize $4 billion in annual sales by the end of the decade.

Read more 
Sales Forecasts: Sanofi to Replace Pfizer's Top Place in 2012

Sales Forecasts: Sanofi to Replace Pfizer's Top Place in 2012

4 Nov 2011

A research firm says Sanofi will retain the top spot until at least 2016, with Pfizer dropping to third place, behind Novartis.

Read more 
Top 500 Global Sustainability Ratings: Baxter and J&J Lead Green Pharma Firms

Top 500 Global Sustainability Ratings: Baxter and J&J Lead Green Pharma Firms

3 Nov 2011

Baxter leads public-company drugmakers in Newsweek's annual top 500 global sustainability ratings.

Read more 
Evonik Agrees to Buy SurModics Pharmaceuticals

Evonik Agrees to Buy SurModics Pharmaceuticals

3 Nov 2011

Following the acquisition of the Resomer business from Boehringer Ingelheim in March, Evonik is now strengthening its formulation services business for pharmaceutical applications and further developing its healthcare business.

Read more 
Sanofi Reorganizing US Research Operations

Sanofi Reorganizing US Research Operations

3 Nov 2011

French drugmaker Sanofi said Wednesday that it's reorganizing research operations in the U.S..

Read more